Fact-checked by Grok 2 weeks ago

Tinea versicolor

Tinea versicolor, also known as pityriasis versicolor, is a common, benign, superficial fungal infection of the skin's stratum corneum caused by an overgrowth of Malassezia species, lipophilic yeasts that are normal commensals on human skin.^[1]^[2] It manifests as asymptomatic or mildly pruritic macules and patches of hypopigmented, hyperpigmented, or erythematous skin with fine scaling, predominantly on the trunk, neck, upper arms, and abdomen, though it can occur on the face in children or oily-skinned individuals.^[3]^[1] The infection is not contagious and thrives in warm, humid environments, leading to higher prevalence in tropical climates and among adolescents and young adults due to increased sebaceous gland activity.^[2]^[4] Risk factors include oily skin, excessive sweating, immunosuppression, and use of occlusive clothing or topical corticosteroids, which promote yeast proliferation by altering the skin's lipid environment.^[3]^[5] Diagnosis is typically clinical, based on the characteristic appearance; Wood's lamp examination may reveal yellow-green fluorescence, while microscopic examination of skin scrapings with a potassium hydroxide (KOH) preparation shows short hyphae and round yeast cells in a "spaghetti and meatballs" pattern, confirming the presence of Malassezia.^[1]^[2] Treatment involves topical antifungals such as azoles (e.g., ketoconazole or clotrimazole creams) or allylamines, often applied for 1–2 weeks, with selenium sulfide or zinc pyrithione shampoos as effective, cost-efficient alternatives for larger areas; oral antifungals like fluconazole or itraconazole may be used for extensive or recurrent cases.^[6]^[1] Although the infection responds well, hypopigmentation or hyperpigmentation may persist for weeks to months until sun exposure evens out skin tone, and recurrence is common in predisposing conditions, necessitating prophylactic measures like monthly antifungal applications during warm seasons.^[2]^[5]

Clinical Features

Signs and Symptoms

Tinea versicolor presents with characteristic skin lesions consisting of multiple, well-demarcated, oval macules or patches that are hypopigmented, hyperpigmented, or erythematous, often exhibiting fine scaling or a velvety texture upon closer inspection.^[1]^[3] The colors of these lesions vary, appearing as white, pink, red, brown, tan, or yellow spots that differ from the surrounding skin tone.^[7]^[8] These lesions commonly affect the upper trunk, including the back and chest, as well as the neck, upper arms, and abdomen.^[1]^[3] In children, involvement of the face may occur, which is less common in adults.^[1] Lesions can become confluent, forming larger irregular patches over time.^[1]^[7] Most cases are asymptomatic, but patients may experience mild itching, which intensifies in hot, humid conditions or with sweating.^[1]^[3] Scaling is often subtle and becomes more apparent when the skin surface is scraped.^[1]^[8] Hypopigmented lesions are particularly noticeable in individuals with darker skin tones, where the contrast with unaffected, tanned skin is pronounced.^[1]^[7] The condition typically has a gradual onset, with lesions persisting or recurring seasonally, and pigmentary changes becoming more evident following sun exposure due to impaired tanning in affected areas.^[3]^[7]

Complications and Prognosis

Tinea versicolor is a benign condition with rare complications, primarily limited to secondary issues arising from patient behavior or persistent cosmetic effects.^[9] Secondary bacterial infections can occasionally occur if scratching leads to skin breakdown, though this is uncommon due to the superficial nature of the infection.^[1] The most notable complication is emotional distress stemming from the visible discoloration, which may cause self-consciousness or psychological impact, particularly in patients with extensive involvement or in social settings.^[10] Dyspigmentation, manifesting as hypopigmented or hyperpigmented patches, often persists for weeks to months after successful antifungal therapy, sometimes leading to perceived treatment failure.^[3]^[1] The prognosis for tinea versicolor is excellent with appropriate treatment, as the infection typically resolves fully without scarring or long-term systemic effects.^[9] However, recurrence is common, affecting 60% to 80% of patients within months to two years without maintenance therapy, particularly in tropical climates or humid environments.^[11] Factors influencing prognosis include adherence to prophylactic regimens, exposure to triggers like heat and humidity, and individual predispositions such as oily skin or family history.^[1] While lesions clear promptly, residual pigment changes may take several months to normalize, but the condition remains non-progressive and manageable with ongoing prevention.^[3]^[9]

Etiology and Pathogenesis

Causative Organism

Tinea versicolor is caused by overgrowth of lipophilic yeasts from the genus Malassezia, formerly known as Pityrosporum, which are normal commensals of human skin.^[1] The primary species implicated include Malassezia globosa, Malassezia furfur, and Malassezia sympodialis, with M. globosa identified as the predominant causative agent in its mycelial form based on molecular and cultural analyses of lesional skin.^[12]^[1] These fungi are dimorphic, existing in both yeast and hyphal (mycelial) phases, and are strictly lipophilic, requiring exogenous lipids such as long-chain fatty acids from sebum for growth and survival.^[9] They colonize sebaceous-rich areas like the trunk, upper arms, and neck, where sebum production supports their proliferation as part of the skin microbiome.^[13] Malassezia species are not transmitted person-to-person, as the infection arises from endogenous overgrowth of resident flora rather than external acquisition.^[14] The shift from commensal yeast to pathogenic mycelial form is triggered by environmental factors favoring hyphal conversion, such as warmth, humidity, and oily skin conditions, without involving contagious spread.^[3] This endogenous nature distinguishes tinea versicolor from other dermatophytoses, emphasizing host and microbial interactions over direct transmission.^[9] Identification of Malassezia in tinea versicolor relies on microscopic examination of skin scrapings treated with 10% potassium hydroxide (KOH), revealing short, curved hyphae interspersed with round yeast cells in a characteristic "spaghetti and meatballs" pattern.^[14] Culture confirmation involves inoculation on lipid-supplemented media, such as olive oil overlay on Sabouraud dextrose agar or specialized formulations like Leeming-Notman agar, where colonies appear creamy-white and yeast-like after incubation at 30–32°C for 7–14 days.^[15]^[16] These methods highlight the organism's lipid dependency and dimorphism, aiding in distinguishing it from other superficial mycoses.^[1]

Pathophysiological Mechanisms

Tinea versicolor arises from the overgrowth of Malassezia species, commensal lipophilic yeasts that normally colonize human skin but shift to a pathogenic state under certain conditions. This transition involves the conversion from the saprophytic yeast form to the mycelial (hyphal) form, which is facilitated by environmental factors such as high humidity and heat, as well as host-related elements like oily skin and immunosuppression.^[9] These triggers promote fungal proliferation within the stratum corneum, where Malassezia adheres to keratinocytes and utilizes skin lipids for growth.^[1] The pathogenic mycelial form exerts biochemical effects on the skin primarily through the production of dicarboxylic acids, including azelaic acid, which competitively inhibits tyrosinase, an enzyme essential for melanin synthesis. This inhibition disrupts melanocyte function and leads to hypopigmentation in affected areas. Additionally, Malassezia secretes lipases that hydrolyze skin lipids into irritant free fatty acids, inducing mild inflammation and contributing to the characteristic fine scaling observed in the disease.^[14]^[15] Host immune responses play a critical role in the pathogenesis, with impaired cell-mediated immunity allowing unchecked fungal proliferation. Specifically, reduced T-cell function, including diminished interferon-gamma production, fails to control Malassezia growth in susceptible individuals. In atopic patients, exposure to Malassezia antigens can trigger a humoral response involving elevated IgE levels, potentially exacerbating the condition through allergic mechanisms.^[9]^[17] Several host factors further promote pathogenesis by altering skin microenvironment or immune competence, including hormonal changes during puberty that increase sebum production, systemic corticosteroid use that suppresses T-cell activity, and malnutrition that compromises overall immunity. Notably, Malassezia remains confined to the superficial layers of the epidermis in tinea versicolor, without invading deeper tissues or bloodstream.^[14]^[9]

Diagnosis

Clinical Evaluation

Clinical evaluation of tinea versicolor begins with a detailed patient history to identify key features suggestive of the condition. Patients often report the gradual onset of skin discoloration over weeks to months, with lesions persisting for variable durations, commonly 1 to 6 months in many cases.^[18] Mild itching is frequently described, which may intensify with heat or humidity, though many cases are asymptomatic.^[7] Exacerbating factors such as excessive sweating, sun exposure, and living or recent travel to tropical or humid climates are commonly elicited, as these environments promote fungal overgrowth.^[3] Inquiry into prior episodes is essential, given the recurrent nature of the infection, with recurrences occurring in about 60% within one year and 80% within two years, along with any previous treatments or family history of similar skin changes.^[19] Physical examination focuses on inspection of the skin, particularly the trunk, neck, and proximal extremities, where non-tender, well-demarcated patches or macules with fine, powdery scales are characteristic.^[14] These lesions, which may appear hypopigmented, hyperpigmented, or erythematous, often coalesce into larger confluent areas and become more apparent against tanned skin after sun exposure.^[7] Gentle scraping of the lesions can reveal subtle scaling, aiding in pattern recognition. Examination under a Wood's lamp may show a distinctive golden-yellow to yellow-orange fluorescence in affected areas, supporting presumptive diagnosis without invasive procedures.^[7] Suspicion for tinea versicolor should arise in adolescents and young adults presenting with truncal lesions, especially in warm or tropical climates, where prevalence can reach up to 50%.^[1] The absence of systemic symptoms, such as fever or malaise, further points toward this benign condition rather than more serious dermatoses.^[20] Differential diagnosis involves distinguishing tinea versicolor from mimicking conditions based on clinical clues. For instance, vitiligo presents with complete depigmentation and lacks scaling, unlike the fine scales and variable pigmentation seen in tinea versicolor.^[1] Pityriasis rosea may be considered due to truncal involvement but features a herald patch and Christmas tree distribution, contrasting with the non-inflammatory, coalescing patches of tinea versicolor.^[1] Other considerations include pityriasis alba or seborrheic dermatitis, where history of atopy or oily scalp involvement helps differentiate.^[1]

Laboratory Confirmation

Laboratory confirmation of tinea versicolor is pursued when clinical findings are equivocal, such as in atypical presentations, treatment failures, or immunocompromised patients.^[1] The primary laboratory method is direct microscopy using a potassium hydroxide (KOH) preparation of skin scrapings, which reveals short, stubby hyphae intermixed with clusters of round yeast cells, classically described as a "spaghetti and meatballs" appearance.^[1]^[5] This test has a sensitivity of approximately 88%, though it may vary based on sampling technique and examiner experience.^[21] Wood's lamp examination can support the diagnosis by demonstrating a characteristic golden-yellow to yellow-orange fluorescence in affected areas, attributed to fungal metabolites like pityrialactone, but it is not diagnostic alone due to potential overlap with other conditions.^[22]^[23] Dermoscopy may reveal characteristic features such as white structureless areas with patchy scaling in skin furrows, serving as a non-invasive aid in diagnosis.^[13]^[24] Fungal culture is rarely performed because Malassezia species are fastidious and require lipid supplementation, such as Sabouraud's dextrose agar overlaid with olive oil, incubated at 30-37°C; positive growth confirms the organism but is time-consuming and yields low positivity rates compared to microscopy.^[25]^[26] Advanced molecular tests, such as polymerase chain reaction (PCR) targeting Malassezia species, offer species identification directly from skin samples and are primarily used in research settings or complex cases, with high accuracy in detecting and differentiating isolates.^[27]^[28] In rare instances of diagnostic uncertainty, a skin biopsy may be indicated, revealing clusters of yeast forms within the stratum corneum on histopathology, often highlighted by periodic acid-Schiff (PAS) staining.^[1]^[29]

Management

Treatment Options

Treatment of tinea versicolor primarily involves antifungal agents to eradicate the Malassezia yeast overgrowth, with topical therapies serving as the first-line approach due to their efficacy and favorable safety profile.^[5] Topical antifungals are recommended for most cases, particularly when the infection is limited in extent, and can achieve clinical and mycological cure rates of 70-90%.^[13] Common topical options include azole antifungals such as ketoconazole 2% shampoo, applied once daily for 5 days, or clotrimazole and miconazole creams applied twice daily for 2-4 weeks; allylamines such as terbinafine 1% cream applied once daily for 1-2 weeks are also effective.^[30]^[13] Selenium sulfide 2.5% lotion or shampoo or zinc pyrithione shampoo is another effective agent, applied daily for 10 minutes and then rinsed off, for 7-14 days.^[6] These treatments typically resolve the infection in 70-90% of cases, though hypopigmentation or hyperpigmentation may persist for 4-8 weeks as skin color normalizes.^[1] For extensive involvement, recurrent disease, or when topical therapy is impractical, oral antifungals are indicated. Fluconazole at 300-400 mg as a single dose is effective, with repeat dosing monthly if needed for recurrence prevention.^[31] Itraconazole 200 mg daily for 5-7 days offers similar efficacy, achieving cure rates comparable to topical agents in broader applications.^[1] Oral therapies also yield resolution in 70-90% of patients, but maintenance regimens may be required for those prone to relapse.^[5] Side effects from topical antifungals are generally mild, including local irritation or dryness, and rarely necessitate discontinuation.^[32] Oral antifungals carry a low risk of hepatotoxicity, though liver function monitoring is advised in patients with preexisting liver disease.^[30] Antifungal resistance is uncommon in Malassezia species.^[5] Special considerations include restricting treatment to topical agents during pregnancy to minimize systemic exposure.^[6] In children, lower doses of oral antifungals are used, with topical options preferred when possible.^[1]

Prevention Strategies

Preventing tinea versicolor focuses on minimizing conditions that favor Malassezia yeast overgrowth, such as heat, humidity, and excess skin moisture or oils. Key hygiene practices include showering promptly after sweating or exercising to keep the skin dry, avoiding heavy oils or moisturizers that can promote fungal proliferation, and using antifungal shampoos prophylactically. For instance, applying 2% ketoconazole shampoo to affected areas once monthly, leaving it on for 5 minutes before rinsing, helps suppress yeast growth and is recommended for those prone to recurrence.^[1]^[29]^[6] Environmental controls are particularly important in humid or tropical climates, where the condition thrives. Individuals should opt for loose-fitting cotton clothing to enhance airflow and reduce skin occlusion, utilize air conditioning to lower ambient humidity, and apply broad-spectrum sunscreen to prevent tanning that accentuates hypopigmented patches. These measures help maintain a less favorable environment for the yeast without relying on active treatment.^[6]^[29]^[33] For high-risk individuals with frequent recurrences, prophylactic regimens may involve topical or oral antifungals administered intermittently. Topical options include seasonal applications of selenium sulfide or ketoconazole shampoos as body washes, while oral fluconazole (300 mg) or itraconazole (200 mg) taken once every 1-2 months has been effective in preventing episodes during warm seasons. These approaches are typically prescribed after initial treatment and tailored to individual needs.^[34]^[6]^[11] Patient education emphasizes early recognition of symptoms like subtle scaling or color changes on the trunk to initiate preventive steps promptly, along with adherence to maintenance regimens to counter the high recurrence rate of 60% within one year and up to 80% within two years without intervention. Consistent use of these strategies can reduce recurrence episodes by approximately 50-70% in susceptible individuals, though no vaccine is currently available for tinea versicolor.^[29]^[11]^[35]

Epidemiology

Global Prevalence

Tinea versicolor, also known as pityriasis versicolor, exhibits significant variation in prevalence globally, primarily influenced by climatic conditions. In temperate climates, such as those in North America and Europe, the prevalence ranges from 1% to 4%, with studies reporting rates around 2-8% in the United States based on dermatological surveys.^[1]^[9] In contrast, tropical and subtropical regions experience much higher rates, often reaching 30% to 50%, particularly in areas like Southeast Asia, sub-Saharan Africa, and Pacific islands such as Samoa, where humid heat fosters the growth of the causative Malassezia fungi.^[36]^[37]^[38] The condition displays distinct seasonal patterns, peaking during warmer months in temperate zones due to increased heat and humidity that promote fungal proliferation. In equatorial and tropical areas, however, tinea versicolor occurs year-round without significant fluctuation, as consistently favorable environmental conditions sustain high incidence.^[1]^[9] Dermatological surveys from the 2020s, including those in diverse populations, confirm these patterns, with summer surges noted in regions like the United States and Europe.^[5] Globally, tinea versicolor contributes to a substantial dermatological burden, with estimates suggesting it accounts for millions of cases annually, though exact figures are challenging due to underreporting in low-resource settings where the cosmetic impacts lead to limited healthcare seeking. Incidence trends remain stable over time, but increased international travel and globalization have heightened recognition and reported cases in non-endemic regions.^[39] No major outbreaks have been documented, reflecting its endemic rather than epidemic nature.^[40]

Risk Factors and Demographics

Tinea versicolor is most prevalent among adolescents and young adults, particularly those aged 15 to 30 years, with incidence peaking during this period due to hormonal changes that increase sebaceous gland activity.^[9] The condition is rare in infants and the elderly, as prepubertal children have lower sebum production and older adults experience reduced skin oiliness.^[9] Regarding sex distribution, the infection affects males and females equally in many populations.^[29] There is no strong ethnic bias in susceptibility beyond environmental influences like climate, but the hypopigmented lesions are more noticeable in individuals with darker skin tones.^[9] Modifiable risk factors include exposure to high humidity and heat, which promote fungal growth on the skin, as well as the use of immunosuppressive medications such as corticosteroids or chemotherapy.^[1] Application of oily skin cosmetics or lotions can exacerbate the condition by providing an ideal lipid-rich environment for the causative yeast, while malnutrition weakens immune defenses against overgrowth.^[1] Unmodifiable risk factors encompass genetic predispositions, such as those linked to increased seborrhea or familial patterns of susceptibility, and underlying medical conditions like HIV or diabetes that impair immune regulation.^[13] Hormonal shifts during pregnancy or the postpartum period also heighten vulnerability by altering skin pH and sebum composition.^[7] Incidence is significantly elevated among immunocompromised individuals, with rates up to several times higher than in the general population, particularly in those with HIV where altered T-cell responses facilitate yeast proliferation.^[1] Studies from underrepresented groups, including Black and Hispanic patients, indicate a higher burden compared to White individuals, potentially influenced by socioeconomic or environmental factors.^[41] Recent data from the 2020s highlight associations with rising obesity rates, where excess body fat alters skin lipid profiles and increases sweating, thereby elevating risk; for instance, overweight individuals showed higher odds of infection in a 2024 study from resettled populations.^[42]

References

[1]
Tinea Versicolor - StatPearls - NCBI Bookshelf
Feb 12, 2024 · Tinea versicolor, or pityriasis versicolor, is a common, benign, superficial fungal skin infection. Saprophytic, lipid-dependent yeast from the ...Introduction · History and Physical · Treatment / Management · Differential Diagnosis
[2]
Tinea versicolor - Medical Encyclopedia - MedlinePlus
Oct 14, 2024 · Causes. Tinea versicolor is fairly common. It is caused by a type of fungus called Malassezia. This fungus is normally found on human skin.
[3]
Tinea versicolor - Symptoms & causes - Mayo Clinic
It's also called pityriasis versicolor. Treatment involves antifungal creams, lotions or shampoos. Skin color may remain uneven for several weeks or months.
[4]
Overview: Tinea versicolor - InformedHealth.org - NCBI Bookshelf
Apr 16, 2025 · Tinea versicolor leads to patches of white or brown skin. · This skin condition is caused by a harmless type of yeast (fungus). · It is more ...
[5]
Tinea versicolor: an updated review - PMC - PubMed Central
Tinea versicolor is a common superficial fungal infection of the skin caused by Malassezia species. Because the clinical manifestations of tinea versicolor are ...Missing: definition | Show results with:definition
[6]
Tinea versicolor - Diagnosis & treatment - Mayo Clinic
Treatment for tinea versicolor usually starts with nonprescription medicine to kill the fungus. If it's not effective, you may need a prescription-strength ...
[7]
Tinea Versicolor: Symptoms, Causes & Treatments - Cleveland Clinic
Tinea versicolor is a common fungal infection that causes discolored skin. People with tinea versicolor develop white, yellow, red, pink or brown spots.Selenium Sulfide Shampoo · Miconazole Ointment or Solution
[8]
Pityriasis Versicolor—A Narrative Review on the Diagnosis and ...
Oct 22, 2023 · PV is characterised by scaly hypopigmented or hyperpigmented patches, primarily affecting the upper trunk, neck, and upper arms. Regarding ...
[9]
Tinea Versicolor: Background, Pathophysiology, Etiology
Jul 3, 2025 · Patients with tinea versicolor often report that the involved skin lesions fail to tan in the summer. Thus, affected areas commonly become more ...
[10]
Anxiety and depression in patients with pityriasis rosea compared to ...
The number of patients with depression in pityriasis rosea and tinea versicolor groups were 11 and 13 respectively. Depression and anxiety scores were highly ...Missing: impact | Show results with:impact
[11]
Efficacy of Itraconazole in the Prophylactic Treatment of Pityriasis ...
Pityriasis versicolor recurs at a variable rate in treated individuals, and 60% to 90% of patients relapse within 2 years in some series. Therefore, it is ...
[12]
Malassezia globosa as the causative agent of pityriasis versicolor
These results support the data previously reported and strongly suggest that M. globosa in its mycelial phase is the causative agent of PV.
[13]
Tinea versicolor (pityriasis versicolor) - UpToDate
Jan 2, 2025 · Etiology – Tinea versicolor is caused by saprophytic, lipid-dependent yeasts in the genus Malassezia, components of normal skin flora.
[14]
Tinea Versicolor - Dermatologic Disorders - Merck Manuals
Classically, it causes the appearance of multiple tan, brown, salmon, pink, or white scaling patches on the trunk, neck, abdomen, and occasionally face.
[15]
Tinea versicolor - Skin nontumor - Pathology Outlines
Dec 4, 2024 · Tinea versicolor is a superficial skin infection with commensal Malassezia species, a dimorphic fungus.Missing: biology | Show results with:biology
[16]
Epidemiology of Malassezia yeasts associated with pityriasis ...
... (tinea) versicolor, we used Leeming-Notman medium to culture patient skin specimens showing positive evidence of Malassezia infection in direct microscopy.
[17]
Immunology of Diseases Associated with Malassezia Species
Jan 1, 2002 · Studies examining cellular and humoral immune responses specific to Malassezia species in patients with Malassezia-associated diseases and ...<|separator|>
[18]
Clinico epidemiological and mycological study of pityriasis ...
Duration of the infection ranged between 1 month to 6 months in 65% while it was more than 1 year in 9% of patients. Recurrence was observed in 35% of them.<|control11|><|separator|>
[19]
[PDF] Clinical aspects of patients with pityriasis versicolor seen at a ...
Past history of pityriasis versicolor was reported by 52.6% (61/116) of the subjects, while 47.4%. (55/116) reported the first episode of the disease during the ...Missing: travel | Show results with:travel
[20]
Tinea Versicolor | Johns Hopkins Medicine
Tinea versicolor is a common fungal skin infection caused by yeast on the skin. It is also called pityriasis versicolor.
[21]
Tinea InVersicolor: A Rare Distribution of a Common Eruption | Cureus
Jan 17, 2020 · Furthermore, in their discussion of bedside dermatologic tests, Wanat et al. report the sensitivity and specificity of KOH preparation to be 88% ...
[22]
Revealing The Unseen: A Review of Wood's Lamp in Dermatology
Wood's lamp displays a yellow-orange fluorescence with tinea versicolor infections due to the porphyrin pityrialactone.42,43 Wood's lamp has limited utility ...
[23]
Wood's Lamp Exam: What It Is, What It's Used for, and ... - WebMD
Aug 9, 2025 · Areas of skin infected with tinea versicolor can be identified by a yellow-orange fluorescence under a Wood's lamp. Porphyria. Porphyria is ...<|separator|>
[24]
Tinea versicolor | Johns Hopkins ABX Guide
Mar 16, 2025 · KOH prep of scales shows short, stubby, blunt-ended interlaced hyphae with clusters of spores and yeast cells ("spaghetti and meatballs" ...
[25]
Mycological study of tinea versicolor - PubMed
Skin scrapings from 100 cases were subjected for culture in Sabouraud's dextrose agar, out of which 60 positive cultures (60%) were obtained.
[26]
Identification of Malassezia species from pityriasis versicolor lesions ...
Nov 5, 2013 · Multiplex PCR detected and differentiated all 55 samples obtained directly from the patients' skin. However, 50 out of 55 samples yielded ...
[27]
https://pubmed.ncbi.nlm.nih.gov/24190515/
[28]
Pityriasis versicolor. Tinea versicolor - DermNet
Pityriasis versicolor is a common yeast infection of the skin, in which flaky discoloured patches appear on the chest and back.Pityriasis versicolor pathology · Selenium sulfide · Malassezia infectionsMissing: secondary | Show results with:secondary
[29]
Therapy of Skin, Hair and Nail Fungal Infections - PMC - NIH
A wide range of different antifungal drugs is effective in pityriasis versicolor [47], and cure rates of over 85% can be achieved. Topically applied azole ...
[30]
Antifungal Treatment for Pityriasis Versicolor - PMC - NIH
Mar 12, 2015 · Background: Pityriasis versicolor (PV), also known as tinea versicolor, is caused by Malassezia species ... PV will persist if left untreated and ...Missing: complications | Show results with:complications
[31]
Oral therapy of common superficial fungal infections of the skin
Four hundred milligrams fluconazole as a single dose and 200 mg itraconazole daily for 5 to 7 days were effective in the treatment of pityriasis versicolor; ...
[32]
Tinea versicolor: Diagnosis and treatment
Using a medicated cleanser once or twice a month, especially during warm and humid periods, can prevent the yeast from overgrowing again. Anti-fungal pills: A ...
[33]
Tinea versicolor: Tips for managing
Protect your skin from the sun. A tan makes tinea versicolor easier to see. Do not use a tanning bed or sun lamp. Again, a tan makes tinea versicolor easier ...Missing: strategies | Show results with:strategies
[34]
Tinea Versicolor Treatment & Management - Medscape Reference
Jul 3, 2025 · Whether it is treated with topical or oral therapy, tinea versicolor has a high rate of recurrence. In most cases, prophylactic topical or oral ...
[35]
Pityriasis Versicolor (Formerly Tinea Versicolor) | Red Book Online
The differential diagnosis includes pityriasis alba, vitiligo, seborrheic ... The organism that causes pityriasis versicolor is commensal and resides on normal ...
[36]
Epidemiological characterization of pityriasis versicolor and ...
The prevalence of PV is higher in tropical climates (nearly 30-40%), compared to that in temperate temperatures (1-4%) [ 16 ].
[37]
Tinea versicolor: Epidemiologic, clinical, and - JAAD
In addition, a single dose of 400 mg of oral ketoconazole eliminates the disease and can be used prophylactically in some cases to prevent recurrence. (J AM ...
[38]
Pityriasis Versicolor—A Narrative Review on the Diagnosis and ...
The recurrence rate is high (up to 80%) [4], with a higher morbidity noted among the individuals with a positive family history of PV [1,8,9]. This fact can be ...
[39]
Ringworm (tinea) - World Health Organization (WHO)
Jun 19, 2025 · Globally, fungal skin infections are estimated to affect more than 650 million people at any time and of these, ringworm accounts for over half ...
[40]
Worldwide trends and future projections of fungal skin disease burden
Jun 4, 2025 · In 2021, there were approximately 1.73 billion global cases of fungal skin diseases. Males had higher age-standardized rates for incidence, ...
[41]
(PDF) Tinea versicolor: an updated review - ResearchGate
Aug 7, 2025 · Tinea versicolor is a common superficial fungal infection of the skin with various clinical manifestations. This review aims to familiarize physicians
[42]
Tinea versicolour in underrepresented groups: An All of Us ... - NIH
Jul 21, 2022 · We found that underrepresented groups in the AoU database including Black patients, Hispanic patients, and participants with physical ...
[43]
Infection patterns of scabies and tinea between inland and resettled ...
Sep 26, 2024 · Moreover, obese and overweight group had higher odds of getting tinea versicolor due to a lower tolerance of heat and hence lead to more active ...